Clinical Trial

PSMA-PET Registry for Recurrent Prostate Cancer

Study Description

PSMA-PET Registry for Recurrent Prostate Cancer

This study aims to institute a province-wide registry leveraging the availability of a new Positron Emission Tomography tracer, [18F]-DCFPyL and PET expertise across Ontario centers to improve our ability to characterize patterns of recurrence and personalize therapies in men with recurrent prostate cancer after primary treatment.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Diagnostic Test - [18F]-DCFPyL PET/ CT scan (PSMA PET)

Participants will undergo re-staging with [18F]-DCFPyL PET/CT Scan (PSMA PET).

Additional Information

Official Study Title

PSMA-PET Registry for Recurrent Prostate Cancer

Clinical Trial ID

NCT03718260

ParticipAid ID

epYz6a